These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2940738)

  • 1. Alloantigen presentation by canine endothelial cells. Presentation of autologous alloantigens in vitro.
    Groenewegen G; Buurman WA; Jeunhomme GM
    Transplantation; 1986 Jun; 41(6):751-4. PubMed ID: 2940738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial cells present alloantigens to unprimed lymphocytes.
    Groenewegen G; Buurman WA
    Scand J Immunol; 1984 Mar; 19(3):269-73. PubMed ID: 6231718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stimulation of lymphocytes by vascular endothelial cells. A study with canine arterial and venous endothelial cells.
    Groenewegen G; Buurman WA; Jeunhomme GM; van der Linden CJ; Vegt PA; Kootstra G
    Transplantation; 1984 Feb; 37(2):206-10. PubMed ID: 6229918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of alloreactive T cells by allogeneic nonprofessional antigen-presenting cells and interleukin-12 from bystander autologous professional antigen-presenting cells.
    de Haan A; van der Gun I; van Dijk E; Hepkema BG; Prop J; de Leij LF
    Transplantation; 2000 Apr; 69(8):1637-44. PubMed ID: 10836375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility antigen class II expressing resting porcine T lymphocytes are potent antigen-presenting cells in mixed leukocyte culture.
    Saalmüller A; Maurer S
    Immunobiology; 1994 Feb; 190(1-2):23-34. PubMed ID: 8082885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
    Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
    J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal allograft rejection: investigation of alloantigen presentation by cultured human renal epithelial cells.
    Kirby JA; Ikuta S; Clark K; Proud G; Lennard TW; Taylor RM
    Immunology; 1991 Mar; 72(3):411-7. PubMed ID: 1827426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
    Qin L; Ding Y; Tahara H; Bromberg JS
    J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantigen-presenting activity of cells from rat small intestine.
    Li X; Tucker J; Quan D; Duff J; Zhong R; Grant D
    Transplant Proc; 1992 Jun; 24(3):1150. PubMed ID: 1534945
    [No Abstract]   [Full Text] [Related]  

  • 12. Alloantigen presenting capacity of human decidual tissue.
    Dorman PJ; Searle RF
    J Reprod Immunol; 1988 Jul; 13(2):101-12. PubMed ID: 2971802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantigen-induced enhancement and suppression of human cytotoxic lymphocyte responses to autologous lymphoblastoid cell lines.
    Zarling JM; Bach FH
    Scand J Immunol; 1978; 8(5):377-85. PubMed ID: 152971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen presentation by B cells. Requirement for IL-1 and IL-6.
    McKenzie D
    J Immunol; 1988 Nov; 141(9):2907-11. PubMed ID: 2971735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated human T cells can present alloantigens but cannot present soluble antigens.
    Gerrard TL; Volkman DJ; Jurgensen CH; Fauci AS
    Cell Immunol; 1985 Oct; 95(1):65-74. PubMed ID: 3928179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets.
    Stock PG; Ascher NL; Chen S; Field J; Bach FH; Sutherland DE
    Transplantation; 1991 Oct; 52(4):704-9. PubMed ID: 1833868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus.
    Damle NK; Engleman EG
    J Exp Med; 1983 Jul; 158(1):159-73. PubMed ID: 6223112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of human cytotoxic lymphocyte responses. I. Non-cytolytic suppression mediated by alloantigen-activated cells.
    Crosier PS; Broom BC
    Immunology; 1981 May; 43(1):11-8. PubMed ID: 6454646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.